By focusing on causal relationships in genome regulation, a new AI method could help scientists identify new immunotherapy techniques or regenerative therapies.

Coupling engineered bacteria with low-power electronics could be highly effective in diagnosis, treatment of bowel diseases.

MIT engineers developed a new way to create these arrays, by scaffolding quantum rods onto patterned DNA.

In addition to turning on genes involved in cell defense, the STING protein also acts as an ion channel, allowing it to control a wide variety of immune responses.

SMART researchers find the enzyne RlmN, which directly senses chemical and environmental stresses, can be targeted in drug development.

MIT researchers find timing and dosage of DNA-damaging drugs are key to whether a cancer cell dies or enters senescence.

BioAutoMATED, an open-source, automated machine-learning platform, aims to help democratize artificial intelligence for research labs.

The new strategy may enable engineered T cells to eradicate solid tumors such as glioblastoma.

The first RNA-guided DNA-cutting enzyme found in eukaryotes, Fanzor could one day be harnessed to edit DNA more precisely than CRISPR/Cas systems.

SMART researchers combine rifaximin and clarithromycin to effectively restore the latter drug's efficacy.